X4 Pharmaceuticals Inc

NASDAQ:XFOR   3:59:55 PM EDT
5.72
-0.11 (-1.89%)
Products

X4 Pharmaceuticals Announces Fast Track Designation Granted By The FDA To Mavorixafor For The Treatment Of Whim Syndrome

Published: 10/08/2020 12:50 GMT
X4 Pharmaceuticals Inc (XFOR) - X4 Pharmaceuticals Announces Fast Track Designation Granted by the FDA to Mavorixafor for the Treatment of Whim Syndrome.